partnership

Portola Pharmaceuticals to merge with Alexion in $1.41bn cash deal

May 6, 2020
Research and Development, Sales and Marketing Alexion, Portola Pharmaceuticals, pharma

Alexion has announced it is to acquire Boston-based blood disorder specialist Portola Pharmaceuticals in a transaction to the value of …

coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

May 6, 2020
Research and Development COVID-19, coronavirus

Vaccines and treatments for COVID-19 continue to dominate the news, as two studies reveal “positive” data for Gilead’s remdesivir in …

trumpppppp

Ousted chief of BARDA says Trump administration ignored COVID-19 warnings

May 6, 2020
Research and Development BARDA, COVID-19, chloroquine, coronavirus, hydroxychloroquine

Ousted Director of the Biomedical Advanced Research and Development Authority (BARDA), Dr Rick Bright, alleges the Trump administration ignored warnings …

jonathanfreve

Jonathan Freve joins Galecto as Chief Financial Officer

May 5, 2020
Manufacturing and Production

The biotech company Galecto Inc have appointed Jonathan Freve as its Chief Financial Officer, and in his role he will …

france-3370174_1280

First French case of COVID-19 occurred in December, a month earlier than previously thought

May 5, 2020
Manufacturing and Production COVID-19, coronavirus

A French patient who suffered from pneumonia in December actually had COVID-19, it has been revealed. Dr Yves Cohen, the …

Malaria treatment in Angola

Scientists in Kenya discover microbe that could stop transmission of malaria

May 5, 2020
Manufacturing and Production malaria, mosquitoes

Researchers studying malaria in Kenya have discovered a microbe that blocks transmission of malaria from mosquitoes which could pave the …

s300_yellow-card-govuk960

MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments

May 5, 2020
Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma

A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agencyโ€™s (MHRA) to track potential …

isle_of_wight

UK contact-tracing app being tested on the Isle of Wight

May 5, 2020
Manufacturing and Production COVID-19, coronavirus

The NHSโ€™s coronavirus contract tracing app has been published to Apple and Googleโ€™s app stores with council staff and healthcare …

shutter

Sanofi and Regeneron’s Libtayo shows durable responses in world’s most common skin cancer

May 5, 2020
Manufacturing and Production, Research and Development Cancer, Libtayo, Regeneron, Sanofi

Sanofi and Regeneronโ€™s have lifted the lid on new topline data on their PD-1 inhibitor Libtayo (cemiplimab) in patients with …

kim_stratton_orphazyme

Working Life Interview: Kim Stratton, CEO, Orphazyme

May 4, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Orphazyme, Working Life

“Every professional faces challenges. As a woman in industry, particularly in leadership, it adds another dimension to those challenges in …

flu_shot_2019

Lonza and Moderna enter agreement to mass produce coronavirus vaccine

May 4, 2020
Sales and Marketing COVID-19, coronavirus

Lonza Group AG and Moderna Inc have entered a deal to develop 1 billion doses of coronavirus vaccines a year. …

gilead-sciences

FDA approves emergency use of Gilead’s remdesivir for hospitalised COVID-19 patients

May 4, 2020
Sales and Marketing COVID-19, FDA, Gilead, coronavirus, remdesivir

Gileadโ€™s antiviral therapy remdesivir has shown tentatively promising efficacy in the race to find an effective treatment for COVID-19, one …

trumpy

Trump vows to reduce Americaโ€™s reliance on foreign drug imports

May 4, 2020
Sales and Marketing COVID-19, coronavirus

President Donald Trump has vowed to cut the USโ€™s reliance on foreign drugs, singling out China and Ireland as countries …

korean_1

UK testing experimental treatment for use in COVID-19 patients

May 4, 2020
Sales and Marketing COVID-19, coronavirus, coronavirus treatment

British scientists are testing an experimental drug to help some of societyโ€™s most vulnerable fight off the COVID-19 coronavirus.

mike

Mike Pompeo says there is evidence COVID-19 was made in a lab, despite US intelligence saying it occurred naturally

May 4, 2020
Sales and Marketing COVID-19, Wuhan Institute of virology, coronavirus, lab, pandemic

US Secretary of State Mike Pompeo claimed that there is evidence the COVID-19 coronavirus was created in a lab, despite …

nhssss

NHS sets out plans to deal with the second phase of the pandemic

May 1, 2020
Medical Communications COVID-19, coronavirus

The NHS has set out plans to step up its non-COVID-19 services over the next six weeks. A letter from …

800px-european_commission_flags

Positive CHMP opinion for BMS and Acceleron’s Reblozyl in transfusion-dependent anaemia sub-populations

May 1, 2020
Medical Communications, Sales and Marketing Acceleron, Bristol-Myers Squibb, EU, Reblozyl

Bristol Myers Squibb and Acceleron Pharmaโ€™s Reblozyl (luspatercept) has secured a positivr opinion from the European Medicines Agencyโ€™s Committee for Medicinal …

facemask

COVID-19 pandemic likely to last two years, study says

May 1, 2020
Medical Communications COVID-19, coronavirus, pandemic

The coronavirus pandemic is likely to last as long as two years and will not be properly controlled until two-thirds …

Vertex’s Kalydeco seizes EU CHMP recommendation for Kalydeco in R117H+ cystic fibrosis

May 1, 2020
Medical Communications, Sales and Marketing Europe, Kalydeco, Vertex, cystic fibrosis

The European Medicines Agencyโ€™s (EMA) Committee for Medicinal Products for Human Use (CHMP) has given its recommendation for the approval …

top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

May 1, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Gilead, UK, coronaviurs

The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gileadโ€™s …

The Gateway to Local Adoption Series

Latest content